<unk> , sold under the brand name Givlaari, is a medication used for the treatment of adults with acute hepatic porphyria.<unk>  is a small interfering RNA (siRNA) directed towards delta-aminolevulinate synthase 1 (ALAS1), an important enzyme in the production of heme. The most common side effects include nausea and injection site reactions. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Givosiran
Bocasan
Mitapivat
Influenzanet
Lumasiran
Tasimelteon
Avacopan
Fenproporex